Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAZA-PET and Pimonidazole in Oral Tongue Cancer
NCT03181035Phase 2Suspended
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jan 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fluoroazomycin arabinoside F-18 in tongue cancer, sponsored by Sunnybrook Health Sciences Centre. Started Jan 2018; status: suspended.
02
Drugs
Fluoroazomycin arabinoside F-18
03
Conditions
tongue cancer
Beyond the preview
Go deeper on NCT03181035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181035.